وَمَنْ أَحْيَاهَا فَكَأَنَّمَا أَحْيَا النَّاسَ جَمِيعًا

Department Publications by Year 93 Faculty

2025

61.

Efficacy and Safety of Esaxerenone for Essential Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Hafez A, Abdelaziz A, Mansour A, Kamal I, Bakr A, Gadelmawla AF, Elsayed H, Mohamed MR, Ali K, Elhelw M

J Clin Med (August 2025) , 14(16)

DOI: doi: 10.3390/jcm14165663

63.

Kojic acid: A River Nile-derived fungal secondary metabolite with preservative potential against Listeria monocytogenes in milk.

Aati HY, Lotfy MM, Al-Tweel A, Al-Enezi B, Abdelkader K, AbouZid SF, Rateb ME, Hassan HM, Mohammed R, El Amir D

Microb Pathog (July 2025) , 204 : 107532

DOI: doi: 10.1016/j.micpath.2025.107532

64.

Medicinal plants: nutritional, immunological and therapeutic role in treating cancer-related malnutrition: a comprehensive review.

El-Saadony MT, Alkafaas SS, Saad AM, Mohammed DM, Korma SA, Salem HM, Abd El-Mageed TA, Elsalahaty MI, Elkafas SS, Mosa WFA, Ahmed AE, Ibrahim EH, Alnadari F, Mathew BT, Abdelhamid AS, Allaban SF, Loutfy SA, Ghosh S, Assal HY, El-Tarabily MK, AbuQamar SF, El-Tarabily KA

Cancer Cell Int (July 2025) , 25(1) : 266

DOI: doi: 10.1186/s12935-025-03720-2

65.

Setting stakeholder-led research priorities for advancing Sexual and Reproductive Health and Rights in Bangladesh using CHNRI method: an icddr,b initiative.

Sayeed A, Saha N, Ameen S, Akter E, Hossain L, Hasan MM, Rahman F, Raza S, Ether ST, Shafiq SS, Mahmood HR, Saberin A, Ashrafee S, Alam HMS, Saha PK, Haider S, Sarkar S, Mahmud M, Islam MJ, Salam SS, Nahar Q, El Arifeen S, Ahmed A, Rahman AE

J Glob Health (July 2025) , 15 : 04186

DOI: doi: 10.7189/jogh.15.04186

66.

Klotho modulation by tempol: a potential therapeutic axis in sepsis.

Al-Kadi A, Anter AF, Rofaeil RR, Sayed-Ahmed MM, Abdel Hafez SMN, Ahmed AF

BMC Cardiovasc Disord (July 2025) , 25(1) : 492

DOI: doi: 10.1186/s12872-025-04738-0

67.

Eco-friendly gemini ionic liquid as a corrosion inhibitor for carbon steel in petroleum pipelines.

Ashmawy AM, Selim YA, Abd-El-Raouf M, Zakaria K, Moustafa YM, Sayed AZ, Alshammari OAO, Abdel-Hameed R

Phys Chem Chem Phys (July 2025) , 27(26) : 14029-14041

DOI: doi: 10.1039/d5cp00349k

68.

Tyrosine kinase inhibitors were well-tolerated among patients with different etiologies of advanced HCC with lower survival in non-viral patients.

Barakat EMF, Kohla M, Dabees H, Shousha HI, Moustafa EF, El-Kassas M, Aziz MS, Elkhateeb E, Abdelaziz AO, Abdelmalek MO, Azmy A, Tawheed A, Aboganob WM, Taha H, Lithy R, Radwan A, Ghoraba D, Sayed H, Nassief A, Elhelbawy M, Nabeel MM, Medhat MA, Askar SR, Marwan E, Rewisha E, Elbaz T, Ahmed SH, Elfouly NF, Abdeen N, Abdelmaksoud AH, Abdeltawab AA, Shamkh MAA, Ramadan A, Abdelrazek YA, Bassam M, Sayed SA, Hussein RS, Alrajhi A, Allam AE, Seyam OA, Said M

Sci Rep (June 2025) , 15(1) : 20323

DOI: doi: 10.1038/s41598-025-05828-x

69.

Clinical significance of the transcription factor (SOX11) expression in the bone marrow of acute myeloid leukemia patients.

Abdel Aziz RS, Radwan EM, Fouad AM, Abdellateif MS, Elfishawi S

World J Clin Oncol (June 2025) , 16(6) : 107271

DOI: doi: 10.5306/wjco.v16.i6.107271